A patient survey collaboration between Care by Design and Project CBD demonstrated that cannabis appears to be an effective pain management tool with few negative unwanted effects. The analysis also discovered that an important reduction in opiate usage among elderly patients while taking medical cannabis.
Pain affects one’s mood, memory, relationships, and overall quality of life. Constant aches and discomfort could cause frustration, depression, anxiety, anger, social isolation, poor sleep, and related health risks. Pain is a problem. A large problem. Plus it becomes worse as we get older: 50 percent of older adults who live by themselves and 75-85 percent from the elderly in care facilities reportedly have problems with chronic pain. With an increasing number of people switching to marijuana for relief, this survey sought to respond to several questions: How satisfied are patients with cannabis being an analgesic? How
does medical marijuana compare with other pain management approaches, specifically, opiates? How can the most common pain management therapies compare in terms of their impact on standard of living? Eight hundred people responded to the survey over a six-week period. Most were between 50 and 70 years of age. Over 80 percent reported they were suffering from chronic pain; near half reported suffering from acute pain; about 40 percent reported experiencing both. On average, respondents had tried four different treatment options for pain. One out of four respondents had tried six or more treatment modalities.
Cannabis, opiates, exercise/physical rehabilitation and NSAIDs all provided noticeable pain alleviation in over fifty percent of patients. Cannabis was the sole therapeutic means for which there have been no reports of worsening pain. In comparison, surgery, exercise, and nerve blockers benefited some but resulted in increased pain in a significant minority of survey participants. Cannabis and exercise/physiotherapy were reported to be the very best therapies for improving total well being measurements. Over half of patients by using these treatment approaches reported improvements in functional ability, mood,
A striking quantity of patients (around half) reported that opiates enjoyed a negative impact on overall wellbeing, and led to worsening mood, energy, functional ability and sleep.Over 50 % of respondents reported that they had used both cannabis and opiates for pain management. Of great interest was the impact of cannabis therapy on opiate usage: Ninety-one percent of the subgroup reported they used fewer or no opiates after beginning cannabis therapy. Sixty-three percent stated that they went off opiates altogether.
Pain affects one’s mood, memory, relationships, and overall standard of living. Chronic pain could cause frustration, depression, anger, social isolation, anxiety, poor sleep, along with other health risks. 50 percent of older adults who live on their own and 75-85 percent from the elderly in care facilities reportedly are afflicted by chronic pain.
This survey-a collaboration between Care By Design and Project CBD-sought to reply to several questions: How satisfied are patients with cannabis as an analgesic? How does medical marijuana compare to other pain management approaches, particularly, opiates? How can the most typical pain management therapies compare when it comes to their effect on total well being?
Eight hundred people, most between 50 to 70 years of age, responded for the survey. Over eighty percent reported they were suffering from chronic pain; close to half reported experiencing acute pain.
An important decline in opiate usage among elderly patients on cannabis therapy was the study’s most notable finding. Over half of respondents reported that they had used both cannabis and opiates for pain management. Of the subgroup, 91 percent said they used fewer or no opiates after beginning cannabis therapy. Sixty-three percent stated that they went off opiates altogether.
Other Key Findings: A striking variety of patients (around half) reported that opiates had a negative effect on overall wellbeing, and ended in worsening mood, energy, functional ability and sleep.
Cannabis was the only therapeutic method for which there were no reports of worsening pain. In comparison, surgery, exercise, and nerve blockers benefited some but resulted in increased pain in a significant minority of survey participants.
There have been no significant variations in outcomes for patients using plant-derived high THC products when compared with whole plant CBD-rich products; both types of cannabis were found to be successful in managing pain. The most typical approach to cannabis administration was vaporization, which can be generally a safe vbgzom mode of administration-barring additives and thinning agents that are available in poor quality vaping products.
In accordance with this patient survey, cannabis therapy is apparently a powerful pain management tool with few negative unwanted effects. Patient-reported outcomes of cannabis’ efficacy combined with its low side-effect profile suggest that it should be viewed as the first-line solution for pain and/or as an adjunct treatment to opiates as opposed to as a medication of last option.